KELSEY RUTTER: Open Payments
NPI 1518686674 · IRMO, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,263 in 62 payments from 26 companies in 2025. Trend: 2023 $242 · 2024 $1,724 · 2025 $1,263
Food & beverage: $1,263
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $175 |
| Otsuka America Pharmaceutical, Inc. | 8 | $152 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $95 |
| Novo Nordisk Inc | 4 | $84 |
| Exact Sciences Corporation | 3 | $82 |
| PFIZER INC. | 4 | $72 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $69 |
| Novartis Pharmaceuticals Corporation | 3 | $50 |
| Ardelyx, Inc. | 2 | $45 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $42 |
Products named: REXULTI, FARXIGA, Kerendia, Wegovy, The Cologuard Plus Collection Kit, PREVNAR 20, CAPLYTA, LEQVIO.
Industry payments across SC — which companies pay providers there.
